Nanomed for implants

Research & Innovation


The Company’s mis­sion state­ment is:

Nanomed­i­cine is a wide field rang­ing from in-​vivo and in-​vitro diag­nos­tics to ther­apy involv­ing tar­geted drug deliv­ery and regen­er­a­tive med­i­cine. It pro­duces new tools and meth­ods that advance sig­nif­i­cantly exist­ing con­ser­v­a­tive prac­tices and it will sig­nif­i­cantly change the course of treat­ing life threat­en­ing dis­eases. Research and devel­op­ment in nanomed­i­cine is expected to offer a pool of novel prod­ucts which will improve the health of patients.

BL Nanobio­med P.C. is a nanomed­ical com­pany that focuses on the devel­op­ment of novel drug deliv­ery nanosys­tems, nanopar­ti­cles and on the devel­op­ment of high-​value nano­ma­te­ri­als for implants in order to over­come the draw­backs of the exist­ing implants.
Our core R&D activ­i­ties entail the design and devel­op­ment of inno­v­a­tive drug deliv­ery nanosys­tems and nanoplat­forms for a wide range of implants and bio­med­ical devices (e.g. car­dio­vas­cu­lar, ortho­pe­dic, sur­gi­cal, neu­ro­log­i­cal implants, lens, patches, etc) for con­trol­lable, tar­geted and sus­tain­able drug release at the dis­eased site.

subscription1-u4099-fr

All rights reserved. Copy­righted by BL Nanobio­med 20142017.
Joomla tem­plates by Joomlashine